Log in to search using one of your social media accounts:

 

Stuart Wenham: scientists pay tribute to 'Einstein of solar world'
University of New South Wales colleagues pay tribute to pioneer with ‘Crocodile Dundee persona’ who died age 60 from malignant melanomaAustralia ’s scientific community has paid tribute to Prof Stuart Wenham, a solar energy pioneer described as the “Einstein of the solar industry”, whose research increased the efficiency of solar cells a hundredfold.Wenham passed away on 23 December, age 60, after suffering from malignant melanoma. He was the director of the Centre of Excellence for Advanced Photovoltaics and Photonics at the University of New South Wales.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 18, 2018 Category: Science Authors: Naaman Zhou Tags: Solar power Science Energy Renewable energy New South Wales Australia news Sydney Environment Australian universities Source Type: news

Presurgical targeted therapy delays relapse of high-risk stage 3 melanoma
(University of Texas M. D. Anderson Cancer Center) A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at The University of Texas MD Anderson Cancer Center report in Lancet Oncology. Patients who had no sign of disease at surgery after combination treatment did not progress to metastasis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2018 Category: Cancer & Oncology Source Type: news

Penn researchers identify new treatment target for melanoma
(University of Pennsylvania School of Medicine) Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous pregnancy with better outcomes after a melanoma diagnosis. Now, a research team from Perelman School of Medicine at the University of Pennsylvania says it may have determined the reason for the melanoma-protective effect. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 16, 2018 Category: International Medicine & Public Health Source Type: news

Researchers identify new way to unmask melanoma cells to the immune system
(Duke University Medical Center) A research team at the Duke Cancer Institute has found a new way to keep the immune system engaged, and is planning to test the approach in a phase 1 clinical trial. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 16, 2018 Category: Biology Source Type: news

Corynebacterium, Kingella Abundance Tied to HNSCC Risk
No correlation for overall microbiome composition with risk of head and neck squamous cell carcinoma (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 12, 2018 Category: Cancer & Oncology Tags: Oncology, ENT, Pathology, Journal, Source Type: news

Beta-Blockers May Enhance Immunotherapy for Melanoma Beta-Blockers May Enhance Immunotherapy for Melanoma
A chart review study suggests that pan-beta-blockers, such as propranolol, may improve outcomes in metastatic melanoma.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 12, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Immunotherapy highly effective in treatment of rare skin cancer, study finds
FINDINGSIn a UCLA-led study, more than two-thirds of people with a rare type of melanoma responded positively to treatment with anti-PD-1 immunotherapies. The findings, which counter the conventional wisdom that a cancer which is highly fibrotic could not respond to immunotherapy, have the potential to help scientists identify those patients most likely to benefit from treatment.BACKGROUNDDesmoplastic melanoma is an uncommon subtype of melanoma that has proven highly resistant to traditional treatment approaches, such as chemotherapy, radiation and surgery. Desmoplastic melanoma tumors have a very dense tissue thought to l...
Source: UCLA Newsroom: Health Sciences - January 12, 2018 Category: Universities & Medical Training Source Type: news

Hydrochlorothiazide and Skin Cancer: Should We Be Worried? Hydrochlorothiazide and Skin Cancer: Should We Be Worried?
Should we be concerned about, or take any action on, a new link found between this common antihypertensive agent and skin cancer?Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 12, 2018 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

Rare form of deadly eye cancer normally diagnosed in older men is killing young women in North Carolina – and doctors don’t know why
(Natural News) Ophthalmologists in North Carolina were reportedly baffled by the increasing cases of an eye cancer known as ocular melanoma across the state, which affected nearly two dozen people and killed four patients within a 15-mile radius of Huntersville. According to experts, the eye disease affects five in one million patients and may commonly manifest in older men in... (Source: NaturalNews.com)
Source: NaturalNews.com - January 11, 2018 Category: Consumer Health News Source Type: news

Is your mole itchy or sore? Do the ABCDE checklist to detect first signs of skin cancer
SKIN cancer is the uncontrolled growth of abnormal skin cells and is one of the most common cancers in the world. There are three main types but melanoma is the most serious, often detected by a new mole or a change int he appearance of an existing one. Doing the ABCDE checklist can detect the first signs. (Source: Daily Express - Health)
Source: Daily Express - Health - January 10, 2018 Category: Consumer Health News Source Type: news

Certain factors may predict lung cancer patients' response to chemotherapy
(Wiley) In a retrospective analysis of 73 lung squamous cell carcinoma patients treated with the chemotherapy regimen of gemcitabine plus cisplatin, higher body mass index and younger age were linked with longer progression-free survival, the length of time that a patient lives with cancer but it does not get worse. Patients with better response to treatment and higher body mass index had longer overall survival in the Thoracic Cancer analysis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 10, 2018 Category: Cancer & Oncology Source Type: news

Rare melanoma type highly responsive to immunotherapy
(H. Lee Moffitt Cancer Center& Research Institute) Desmoplastic melanoma is a rare subtype of melanoma that is commonly found on sun-exposed areas. Treatment is difficult because these tumors are often resistant to chemotherapy and lack actionable mutations commonly found in other types of melanoma. However, Moffitt Cancer Center researchers report in the Jan. 10 issue of Nature that patients with desmoplastic melanoma are more responsive to immune-activating therapies than previously assumed. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 10, 2018 Category: Cancer & Oncology Source Type: news

Piers Morgan met his 'saviour' who prevented his cancer
Gillian Nuttal, founder of Melanoma UK, noticed a blemish on 52-year-old Piers' chest while watching ITV's Serial Killer last November and contacted him to advise he got it checked. (Source: the Mail online | Health)
Source: the Mail online | Health - January 9, 2018 Category: Consumer Health News Source Type: news

Medical News Today: Existing drug may improve melanoma survival
New research shows that an existing, widely prescribed drug may serve to boost the efficacy of immunotherapy in the treatment of advanced melanoma. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 9, 2018 Category: Consumer Health News Tags: Melanoma / Skin Cancer Source Type: news

Neoplastic Meningitis Due to Lung, Breast, and Melanoma Mets Neoplastic Meningitis Due to Lung, Breast, and Melanoma Mets
Determining how to treat patients with neoplastic meningitis can be challenging. Are intra-CSF chemotherapeutic agents effective?Cancer Control: Journal of the Moffitt Cancer Center (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 9, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Research: Melanoma patients may live longer taking beta blockers
Melanoma patients who take a drug designed prevent heart attacks and lower blood pressure might live longer, according to researchers at Penn State. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 8, 2018 Category: Consumer Health News Source Type: news

5-FU Cream Reduces Surgery in High-Risk SCC Patients 5-FU Cream Reduces Surgery in High-Risk SCC Patients
Use of a topical 5-FU cream for patients with squamous cell carcinoma (SCC) reduces the need for surgery on their face and ears, although the chemopreventive effect wanes over time.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 8, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Sensor worn on the thumbnail could prevent skin cancer
UV Sense, which launched in the US last week, is due to be available in the UK in 2019. Its price is unclear. Melanoma affects more than 15,000 new people every year in the UK, with UV being the main cause. (Source: the Mail online | Health)
Source: the Mail online | Health - January 8, 2018 Category: Consumer Health News Source Type: news

Night shifts raise women's chances of cancer by 19%
Skin cancer was raised by 41%, breast cancer by 32% and stomach cancer by 18%, found Sichuan University in China. Night-shift nurses were found to have the biggest risk of breast cancer – 58%. (Source: the Mail online | Health)
Source: the Mail online | Health - January 8, 2018 Category: Consumer Health News Source Type: news

Medicinal Cream May Help Stop Skin Cancer's Return
Title: Medicinal Cream May Help Stop Skin Cancer's ReturnCategory: Health NewsCreated: 1/5/2018 12:00:00 AMLast Editorial Review: 1/8/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 8, 2018 Category: Cancer & Oncology Source Type: news

Beta blockers may boost immunotherapy, help melanoma patients live longer
(Penn State) Melanoma patients who took a specific type of beta blocker while receiving immunotherapy lived longer than patients who received immunotherapy alone, according to researchers. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 8, 2018 Category: Biology Source Type: news

Hydrochlorothiazide May Up Basal, Squamous Cell Cancer Risk
Increased risk for basal cell carcinoma, squamous cell carcinoma, with dose - response relationship (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 6, 2018 Category: Cancer & Oncology Tags: Cardiology, Dermatology, Family Medicine, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news

Eye cancer cluster affects dozens in North Carolina
Nearly two dozen cases of ocular melanoma have been diagnosed in and near Huntersville, North Carolina, and researchers have not found any environmental or genetic link. (Source: the Mail online | Health)
Source: the Mail online | Health - January 6, 2018 Category: Consumer Health News Source Type: news

Medicinal Cream May Help Stop Skin Cancer's Return
The study tracked outcomes for just over 930 U.S. veterans who averaged 70 years of age. (Source: WebMD Health)
Source: WebMD Health - January 5, 2018 Category: Consumer Health News Source Type: news

Fluorouracil Tied to Reduced Surgery for Squamous Cell CA
Reduced risk of squamous cell carcinoma, but not basal cell carcinoma, for one year in at - risk veterans (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 5, 2018 Category: Cancer & Oncology Tags: Dermatology, Oncology, Pharmacy, Journal, Source Type: news

Medicinal Cream May Help Stop Skin Cancer ’ s Return
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 5, 2018 Category: Cancer & Oncology Tags: Dermatology, Nursing, Oncology, Pharmacy, News, Source Type: news

Medical News Today: Your gut microbes may give melanoma treatment a boost
People with advanced melanoma who had healthy levels of specific gut bacteria responded better to immunotherapy than those who did not, a new study found. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 5, 2018 Category: Consumer Health News Tags: Melanoma / Skin Cancer Source Type: news

Transplantation and Risk for Malignant Melanoma Transplantation and Risk for Malignant Melanoma
A study of renal transplant patients shows a 5x increased risk for malignant melanoma.Medscape Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 5, 2018 Category: Consumer Health News Tags: Dermatology Viewpoint Source Type: news

5-FU Cream May Help Stop Skin Cancer's Return
FRIDAY, Jan. 5, 2018 -- For people who've battled certain common forms of skin cancer, use of a generic cream called 5-FU may greatly reduce the odds that the disease will come back, new research shows. The study tracked outcomes for just over 930... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 5, 2018 Category: General Medicine Source Type: news

Medicinal Cream May Help Stop Skin Cancer's Return
FRIDAY, Jan. 5, 2018 -- For people who've battled certain common forms of skin cancer, use of a generic cream called 5-FU may greatly reduce the odds that the disease will come back, new research shows. The study tracked outcomes for just over 930... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 5, 2018 Category: General Medicine Source Type: news

Dirt-dwelling microbe produces potential anti-melanoma weapon
A type of soil-dwelling bacterium produces molecules that induce death in melanoma cells, research at Oregon State University shows. The molecule is a secondary metabolite, also known as a natural product, of Streptomyces bottropensis, and its properties are important because there are not many therapies that effectively manage melanoma, the most dangerous form of skin cancer. (Source: World Pharma News)
Source: World Pharma News - January 5, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Medicinal Cream May Help Stop Skin Cancer's Return
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - January 5, 2018 Category: Cancer & Oncology Source Type: news

A Little Dab'll Do Ya to Prevent Squamous Cell Carcinoma (CME/CE)
(MedPage Today) -- But side effects weren't negligible (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - January 4, 2018 Category: Dermatology Source Type: news

Age May Be a Factor in Facial Skin Cancer Treatment Age May Be a Factor in Facial Skin Cancer Treatment
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 4, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Skin Cancer
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 4, 2018 Category: General Medicine Source Type: news

Researchers create novel compound targeting melanoma cells
(Boston University School of Medicine) An international team of researchers has developed a novel compound that successfully inhibits growth of melanoma cells by targeting specific epigenetic modifying proteins in these cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 4, 2018 Category: International Medicine & Public Health Source Type: news

Dirt-dwelling microbe produces potential anti-melanoma weapon
(Oregon State University) A type of soil-dwelling bacterium produces molecules that induce death in melanoma cells, research at Oregon State University shows. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 4, 2018 Category: Cancer & Oncology Source Type: news

Specific microbes in digestive tract can boost success for cancer immunotherapy
(University of Chicago Medical Center) Specific strains of intestinal bacteria can improve the response rate to immunotherapy for patients being treated for advanced melanoma. Patients with a higher ratio of 'beneficial' bacteria to 'non-beneficial' bacteria all showed a clinical response: a reduction in tumor size. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 4, 2018 Category: Cancer & Oncology Source Type: news

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Preclinical mouse models suggest that the gut microbiome modulates tumor response to checkpoint blockade immunotherapy; however, this has not been well-characterized in human cancer patients. Here we examined the oral and gut microbiome of melanoma patients undergoing anti–programmed cell death 1 protein (PD-1) immunotherapy (n = 112). Significant differences were observed in the diversity and composition of the patient gut microbiome of responders versus nonresponders. Analysis of patient fecal microbiome samples (n = 43, 30 responders, 13 nonresponders) showed significantly higher alpha diversity (P
Source: ScienceNOW - January 4, 2018 Category: Science Authors: Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., Cogdill, A. P., Zhao, L., Hudgens, C. W., Hutchinson, D. S., Manzo, T., Petaccia de Macedo, M., Cotechini, T., Tags: Immunology, Medicine, Diseases reports Source Type: news

The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Anti–PD-1–based immunotherapy has had a major impact on cancer treatment but has only benefited a subset of patients. Among the variables that could contribute to interpatient heterogeneity is differential composition of the patients’ microbiome, which has been shown to affect antitumor immunity and immunotherapy efficacy in preclinical mouse models. We analyzed baseline stool samples from metastatic melanoma patients before immunotherapy treatment, through an integration of 16S ribosomal RNA gene sequencing, metagenomic shotgun sequencing, and quantitative polymerase chain reaction for selected bacteria....
Source: ScienceNOW - January 4, 2018 Category: Science Authors: Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.-L., Luke, J. J., Gajewski, T. F. Tags: Immunology, Medicine, Diseases reports Source Type: news

Age may be a factor in facial skin cancer treatment
(Reuters Health) – - In very elderly patients, less aggressive skin cancers on the face might not always need to be treated, a new study suggests. (Source: Reuters: Health)
Source: Reuters: Health - January 3, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Predicting Prognosis in Submucosal Invasive Esophageal SCC Predicting Prognosis in Submucosal Invasive Esophageal SCC
This study sought to identify histopathological characteristics that could predict lymph node metastasis in submucosal invasive esophageal squamous cell carcinoma.American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 3, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

In clinical trial, cream reduces squamous cell carcinoma risk
(Brown University) Results of a new randomized, double-blinded, controlled clinical trial in veterans showed a 75 percent reduction in the risk of needing surgery to treat a squamous cell carcinoma for a year after applying a skin cream for up to four weeks. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 3, 2018 Category: Cancer & Oncology Source Type: news

Could viruses take cancer immunotherapy to the next level?
(The Ottawa Hospital) Immunotherapy, which helps the body's immune system attack cancer, has revolutionized treatment for cancers such as melanoma and leukemia. However, many other kinds of cancer remain resistant. A new study suggests that a combination of two immunotherapies (oncolytic viruses and checkpoint inhibitors) could be much more successful. This combination could cure 60-90 percent of mice in aggressive breast cancer models. Human trials are ongoing, in other kinds of cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 3, 2018 Category: Cancer & Oncology Source Type: news

Mother with rare eye cancer gives birth to healthy twins
Jessica Boesmiller, 37, from Charlotte, North Carolina, was diagnosed with ocular melanoma while eight months pregnant and had her right eye removed three weeks later. (Source: the Mail online | Health)
Source: the Mail online | Health - January 2, 2018 Category: Consumer Health News Source Type: news

Atopic Dermatitis Associated With Higher Risk of Skin Cancer
Individuals with a history of atopic dermatitis have a higher risk of squamous cell carcinoma development (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 29, 2017 Category: Cancer & Oncology Tags: Dermatology, Family Medicine, Internal Medicine, Allergy, Nursing, Oncology, Pathology, Pediatrics, Journal, Source Type: news

Melanoma skin cancer: Early symptom spotted on Piers Morgan by an eagle-eyed TV viewer
MELANOMA causes the most skin cancer deaths in the UK; one eagle-eyed viewer spotted an early symptom of the condition on Piers Morgan last month. (Source: Daily Express - Health)
Source: Daily Express - Health - December 27, 2017 Category: Consumer Health News Source Type: news

Common BP Drug Tied to Increased Risk of Skin Cancer Common BP Drug Tied to Increased Risk of Skin Cancer
People who take a certain diuretic prescribed to control fluid retention and treat high blood pressure may be more likely to get skin cancer than other individuals, a Danish study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 27, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Nanobiotix ’s nanoparticle-immunotherapy trial wins FDA approval
Nanobiotix (EMA:NANO) said today that the FDA has approved its IND application for a cancer trial combining its radiotherapy-activated nanoparticle tech with an anti-PD1 antibody. The Phase I/II trial is slated to evaluate the safety and efficacy of Nanobiotix’s NBTXR3 product administered with checkpoint inhibitors in three groups of patients with recurrent or metastatic head and neck squamous cell carcinoma or with metastatic non-small cell lung cancer. Get the full story at our sister site, Drug Delivery Business News. The post Nanobiotix’s nanoparticle-immunotherapy trial wins FDA approval appeare...
Source: Mass Device - December 26, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Food & Drug Administration (FDA) Oncology Pharmaceuticals Wall Street Beat nanobiotix Source Type: news

Common blood pressure drug tied to increased risk of skin cancer
(Reuters Health) - People who take a certain water pill prescribed to control fluid retention and treat high blood pressure may be more likely to get skin cancer than other individuals, a Danish study suggests. (Source: Reuters: Health)
Source: Reuters: Health - December 22, 2017 Category: Consumer Health News Tags: healthNews Source Type: news